Crestor
Product Images NDC 43353-290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 43353-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40mg (43353 031)

Bottle Label 40mg (43353 031)
Rosuvastatin Calcium (Crestor) is a medication available in the form of 40mg 15 tablets. The manufacturer is IPR Pharmaceuticals, Inc. and repackaged by Aphen Pharma. The storage condition required for this medication is between 20.25 degrees C (877 degrees F) and it should be kept away from children. The medication batch number marked as P290Z and NDC# is 43353-0031-15.*
FDA Label Image

Bottle Label 20mg (43353 289)

Bottle Label 20mg (43353 289)
Rosuvastatin Calcium (Crestor) is a medication available in the form of 20mg tablets. This package includes 15 tablets and has a National Drug Code (NDC) of 43353-0289-15. Keep the medication in a controlled room temperature between 20-25 degrees Celsius, and out of the reach of children. This medication is manufactured by IPR Pharmaceuticals in Carolina, PR and repackaged by Aphen Pharma in Cookeville, TH. Batch number P290Z is also provided.*
FDA Label Image

Bottle Label 10mg (43353 290)

Bottle Label 10mg (43353 290)
This is a description of a medication called Rosuvastatin Calcium, specifically the 10mg 15 tablet package under the brand name Crestor. The manufacturer is listed as IPR Pharmaceuticals, Inc from Carolina, PR. The medication should be stored at a temperature between 20.25 degrees C and protected in a USP container. It warns to keep the medication away from children. Lastly, it was repackaged by Aphen Pharma in Cookeville, TN under Batch P290Z.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Strucural Formula (Cbc3470f 9033 4200 Abbd A3ab605e5a66 01)

FDA Label Image

Figure One (Cbc3470f 9033 4200 Abbd A3ab605e5a66 02)

FDA Label Image

Figure Two (Cbc3470f 9033 4200 Abbd A3ab605e5a66 03)

Figure Two (Cbc3470f 9033 4200 Abbd A3ab605e5a66 03)
This appears to be statistical data related to the incidence of an event, possibly in a clinical trial. The top section indicates a cumulative incidence percentage, and the middle section includes a hazard ratio and related statistical values. The final section displays the number at risk and years elapsed. Without additional context or information about what event is being measured, it is difficult to provide a more specific description.*
FDA Label Image

Figure Three (Cbc3470f 9033 4200 Abbd A3ab605e5a66 04)

Figure Three (Cbc3470f 9033 4200 Abbd A3ab605e5a66 04)
This is a table showing the number of events and related statistics for two groups of participants (Roswa2omg and Placebo2omg) in a clinical trial. The data includes the primary endpoint and various other outcomes related to cardiovascular events. The "HR" and "HazwdRato" columns may represent hazard ratios or other statistical measures.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.